Alliancebernstein L.P. Ab Cellera Biologics Inc. Transaction History

Alliancebernstein L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $154,335 - $234,068	39,472 New	39,472 $225,000
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $1.33 Million - $2.48 Million	233,100 New	233,100 $2.48 Million
Q1 2022 May 13, 2022	SELL	$7.46 - $14.14 $932,500 - $1.77 Million	-125,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $1.62 Million - $2.22 Million	125,000 New	125,000 $1.79 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.